Philippe GORRY : Citation Profile


Are you Philippe GORRY?

Université de Bordeaux

1

H index

0

i10 index

9

Citations

RESEARCH PRODUCTION:

3

Articles

64

Papers

1

Chapters

RESEARCH ACTIVITY:

   9 years (2010 - 2019). See details.
   Cites by year: 1
   Journals where Philippe GORRY has often published
   Relations with other researchers
   Recent citing documents: 6.    Total self citations: 1 (10 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pgo436
   Updated: 2020-05-23    RAS profile: 2020-03-23    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Zumpe, Martin (3)

Lung, Yannick (3)

Montalban, Matthieu (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Philippe GORRY.

Is cited by:

Bornmann, Lutz (3)

Hanks, Andrew (1)

Cites to:

Bornmann, Lutz (2)

Leydesdorff, Loet (2)

Teixeira, Aurora (1)

Main data


Where Philippe GORRY has published?


Journals with more than one article published# docs
Scientometrics2

Working Papers Series with more than one paper published# docs
Post-Print / HAL62

Recent works citing Philippe GORRY (2019 and 2018)


YearTitle of citing document
2020Challenges for children’s participation: Child activism for ending child marriage. (2020). Kay, E ; Cuevas-Parra, Patricio. In: Children and Youth Services Review. RePEc:eee:cysrev:v:108:y:2020:i:c:s0190740919304712.

Full description at Econpapers || Download paper

2019Forward search path count as an alternative indirect citation impact indicator. (2019). Jiang, Xiaorui ; Zhuge, Hai. In: Journal of Informetrics. RePEc:eee:infome:v:13:y:2019:i:4:s1751157719300094.

Full description at Econpapers || Download paper

2018Analysing the variation tendencies of the numbers of yearly citations for sleeping beauties in science by using derivative analysis. (2018). Fang, Hui. In: Scientometrics. RePEc:spr:scient:v:115:y:2018:i:2:d:10.1007_s11192-018-2687-9.

Full description at Econpapers || Download paper

2018Identifying single influential publications in a research field: new analysis opportunities of the CRExplorer. (2018). Thor, Andreas ; Mutz, Rudiger ; Marx, Werner ; Bornmann, Lutz. In: Scientometrics. RePEc:spr:scient:v:116:y:2018:i:1:d:10.1007_s11192-018-2733-7.

Full description at Econpapers || Download paper

2018Identifying “hot papers” and papers with “delayed recognition” in large-scale datasets by using dynamically normalized citation impact scores. (2018). Bornmann, Lutz ; Ye, Fred Y. In: Scientometrics. RePEc:spr:scient:v:116:y:2018:i:2:d:10.1007_s11192-018-2772-0.

Full description at Econpapers || Download paper

2020Identifying ‘associated-sleeping-beauties’ in ‘swan-groups’ based on small qualified datasets of physics and economics. (2020). Ye, Fred Y ; Zhang, Helena H. In: Scientometrics. RePEc:spr:scient:v:122:y:2020:i:3:d:10.1007_s11192-020-03359-y.

Full description at Econpapers || Download paper

Works by Philippe GORRY:


YearTitleTypeCited
2012Construction politique des marchés et politiques des prix. Le cas de lindustrie pharmaceutique In: Post-Print.
[Citation analysis]
paper0
2011Regulating the drugs market in the EU: the contradiction between safety, innovation and access to care In: Post-Print.
[Citation analysis]
paper0
2011Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS) In: Post-Print.
[Citation analysis]
paper0
2013CH2 Une demande structurée par les prescripteur & CH3 Un système dominé par les firmes multinationales pharmaceutiques In: Post-Print.
[Citation analysis]
paper0
2010The political construction of orphan drugs market: between innovation & access to care In: Post-Print.
[Citation analysis]
paper0
2010Impact of market exclusivity versus IP protection in fostering innovation for rare diseases In: Post-Print.
[Citation analysis]
paper0
2012Schéma régional de lenseignement supérieur, de la recherche & de linnovation In: Post-Print.
[Citation analysis]
paper0
2013The EU’s Government of Pharmaceuticals: Incompleteness Embraced In: Post-Print.
[Citation analysis]
paper0
2018Exploring the historical roots of mesenchymal stem cell research using reference publication year spectroscopy In: Post-Print.
[Citation analysis]
paper0
2019Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies In: Post-Print.
[Citation analysis]
paper0
2018Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies.(2018) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
chapter
2016Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies.(2016) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 0
paper
2017Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies..(2017) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
paper
2015Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies.(2015) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 0
paper
2016Health innovation for rare diseases In: Post-Print.
[Citation analysis]
paper0
2014Building an orphan drug market database to enpower decision making by patient organizations & pharma-biotech companies In: Post-Print.
[Citation analysis]
paper0
2014Les enjeux de la reconnaissance de la radiologie interventionnelle : un travail de recherche interdisciplinaire (sociologie, économie, droit) In: Post-Print.
[Citation analysis]
paper0
2015La construction des catégories diagnostiques de maladie mentale? In: Post-Print.
[Citation analysis]
paper0
2015La construction des catégories diagnostiques de maladie mentale.(2015) In: Revue de la Régulation - Capitalisme, institutions, pouvoirs.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
article
2015Mapping scientific dynamics in « Regenerative Medicine » research, Tissue Engineering Part A, 21, S1 In: Post-Print.
[Citation analysis]
paper0
2014Institutionnalisation des politiques publiques de santé & diffusion de l’innovation médicale In: Post-Print.
[Citation analysis]
paper0
2014Approche quantitative de la diffusion d’un innovation: exemple de la radiologie interventionnelle In: Post-Print.
[Citation analysis]
paper0
2014Institutionalizarion of public policies & diffusion of innovation: the case of interventional radiology In: Post-Print.
[Citation analysis]
paper0
2014Diagnostic prénatal non invasif sur sang maternel & Propriété Intellectuelle: entre éthique de la santé et efficience du marché In: Post-Print.
[Citation analysis]
paper0
2015Intellectual Property Rights and Traditional Knowledge: to which extend biodiversity is preempted at the global level In: Post-Print.
[Citation analysis]
paper0
2015Charles Dotter & the birth of Interventional Radiology: A sleeping beauty with a restless sleep In: Post-Print.
[Citation analysis]
paper0
2015L’histoire de la radiologie interventionnelle: développement et diffusion d’une innovation médicale In: Post-Print.
[Citation analysis]
paper0
2016Serendipity and university technology transfer: a case study. In: Post-Print.
[Citation analysis]
paper0
2016Empirical economic analysis of orphan drug legislation impact on innovation In: Post-Print.
[Citation analysis]
paper0
2016Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation.(2016) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 0
paper
2016Pharma Competitive Intelligence using open source data and visualization tool: towards metrics for drug R&D milestones In: Post-Print.
[Citation analysis]
paper0
2016Biodiversity Sustainability of Phytomedicine Research: a 3-dimensions analysis around the North-South divide In: Post-Print.
[Citation analysis]
paper0
2016Empirical Economic Analysis of Orphan Drug Innovation In: Post-Print.
[Citation analysis]
paper1
2017Empirical Economic Analysis of Orphan Drug Innovation.(2017) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 1
paper
2016Empirical Economic Analysis of Orphan Drug Innovation.(2016) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 1
paper
2017Orphan Drugs: Why the US legislation approves more than the EU? In: Post-Print.
[Citation analysis]
paper0
2017Social Recognition of a Medical Innovation: the case of Interventional Radiology in Oncology In: Post-Print.
[Citation analysis]
paper0
2017Neologisms and affiliation name: a bibliometric perspective on the institutionalization of interventional radiology In: Post-Print.
[Citation analysis]
paper0
2017Evolution des prescriptions de médicaments orphelins en cancérologie : en France, et à l’échelle d’un établissement hospitalier In: Post-Print.
[Citation analysis]
paper0
2016Evolution des prescriptions de médicaments orphelins en cancérologie: en France et à l’échelle d’un établissement hospitalier.(2016) In: Post-Print.
[Citation analysis]
This paper has another version. Agregated cites: 0
paper
2018Orphan Drug Market Exclusivity Extension versus Patent Monopoly In: Post-Print.
[Citation analysis]
paper0
2018Does Orphan Drug market exclusivity incentive sustains drug development for rare diseases ? In: Post-Print.
[Citation analysis]
paper0
2018Naming institution after neologism as marker of the institutionalization of new discipline In: Post-Print.
[Citation analysis]
paper0
2018Delayed Recognition in Science: Different Causes of Sleeping and Awakening of Discoveries In: Post-Print.
[Citation analysis]
paper0
2014Ultrasons focalisés de haute intensité : analyse des dynamiques d’innovations In: Post-Print.
[Citation analysis]
paper0
2015Medical literature imprinting by pharma ghost writing: a scientometric evaluation In: Post-Print.
[Citation analysis]
paper0
2015Mapping scientific dynamics in « Regenerative Medicine » research In: Post-Print.
[Citation analysis]
paper0
2015Diffusion of Interventional Radiology and Health Technology Assessment: the case of radiofrequency treatment in oncology In: Post-Print.
[Citation analysis]
paper0
2016Towards a Patent landscaping of Regenerative Medicine In: Post-Print.
[Citation analysis]
paper0
2017Angiogenesis inhibitors drug pipeline landscape In: Post-Print.
[Citation analysis]
paper0
2017Orphan Drug legislation: evaluation of the impact of market exclusivity extension In: Post-Print.
[Citation analysis]
paper0
2017Science and Technology Indicators of Microalgae-Based Biofuel Research In: Post-Print.
[Citation analysis]
paper0
2017The Dissemination of the Concept of “Interventional Radiology” in Medical and Scientific Literature, In: Post-Print.
[Citation analysis]
paper0
2018Impact of Health Technology Assessment on Innovation Diffusion: the case of techniques in Interventional Radiology. In: Post-Print.
[Citation analysis]
paper0
2019Market Valuation of FDA Orphan Drug Regulatory Events In: Post-Print.
[Citation analysis]
paper0
2019Global overview of patenting landscape in unmanned aerial vehicles. In: Post-Print.
[Citation analysis]
paper0
2019Drug Safety scientometrics overview highlights public health issues. In: Post-Print.
[Citation analysis]
paper0
2013HTA National Public Policy and Their Socio-Economic Environment: A European Perspective In: Post-Print.
[Citation analysis]
paper0
2019R&D incentives and innovation spillovers: evidence from the European orphan drug regulation. In: Post-Print.
[Citation analysis]
paper0
2013Analyse sectorielle, technologique et économique, du marché des médicaments orphelins. In: Post-Print.
[Citation analysis]
paper0
2013A patent landscaping of medicinal plants extracts In: Post-Print.
[Citation analysis]
paper0
2013The scientific-knowledge based institutionalization of Health Technology Assessment: a bibliometric and network analysis In: Post-Print.
[Citation analysis]
paper0
2015La construction des catégories diagnostiques de maladie mentale In: Post-Print.
[Citation analysis]
paper0
2015Targeting α-synuclein for treatment of Parkinsons disease: mechanistic and therapeutic considerations. In: Post-Print.
[Citation analysis]
paper0
2013Health Technology Assessment Agencies and their economic environment: a European perspective. In: Post-Print.
[Citation analysis]
paper0
2017Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021. In: Working Papers.
[Citation analysis]
paper0
2016“Sleeping beauty” and her restless sleep: Charles Dotter and the birth of interventional radiology In: Scientometrics.
[Full Text][Citation analysis]
article8
2018Delayed recognition of Judah Folkman’s hypothesis on tumor angiogenesis: when a Prince awakens a Sleeping Beauty by self-citation In: Scientometrics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated May, 3 2020. Contact: CitEc Team